Mesenchymal stem cells (MSCs) are adult stem cells able to self-renewal or differentiation into different cell types, including chondrocytes. N-Glycans are post-translational modifications of glycoproteins that contribute to vital cell functions. In this work, we examined the cell surface N-glycome of human MSCs isolated from bone marrow to identify biomarkers for chondrogenic differentiation. In addition, we investigated for the first time the N-glycome of MSCs upon dedifferentiation and aging. Cell surface glycoproteins were released by tryptic digestion, then N-glycans were enzymatically cleaved, purified, permethylated, and analyzed by MALDI-TOF-MS combined with exoglycosidase digestions. We were able to detect 68 signals, comprising paucimannose, high-mannose, hybrid, and complex-type N-glycans, as well as structures containing polylactosamine motifs. A statistically significant decrease in antennarity and galactosylation, accompanied by an increase in sialylation, was observed during chondrogenic differentiation. Comparison of MSCs at passage 3 and passage 8 revealed increased levels of paucimannosylation, hybrid-type glycans, and sialylation, together with decreased biantennarity, bigalactosylation, and core-fucosylated N-glycans. Dedifferentiated MSCs exhibited a stem cell-like N-glycosylation profile, although statistically significant differences were still detected. These data show that the N-glycosylation profile of MSCs may serve as an indicator of the differentiation stage, dedifferentiation, and aging for the quality control of MSCs.
Montacir et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: